NCT05681221

Brief Summary

Could the clinical and radiographic success of Nano Silver Particles and Calcium Hydroxide be comparable to that of Triple Antibiotic Paste as antibacterial agents for Lesion Sterilization and Tissue Repair (LSTR) in necrotic second primary molars?

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 12, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

February 20, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

January 12, 2023

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

December 13, 2022

Last Update Submit

December 26, 2022

Conditions

Keywords

primary teethLSTRnecrotic

Outcome Measures

Primary Outcomes (4)

  • Pathological mobility

    presence/ absence. Mobility test by applying pressure using the handle of dental mirrors

    1 year.

  • Post-operative pain

    presence/ absence. Verbal question to patient/ parent.

    1 year.

  • Soft tissue pathology

    presence/ absence. Visual clinical examination

    1 year.

  • Pain to percussion

    presence/ absence. Percussion test by the handle of the dental mirror

    1 year.

Secondary Outcomes (2)

  • Absence of furcation or periapical radiolucency

    1 year.

  • Absence of external or internal root resorption

    1 year.

Study Arms (2)

LSTR in necrotic primary second molar using TAP

ACTIVE COMPARATOR

Triple antibiotic paste (TAP) is considered the gold standard in LSTR. It is a combination of ciprofloxacin, metronidazole and minocycline. Many anaerobic bacteria are resistant to ciprofloxacin. Hence, it is often used with metronidazole in treating mixed infections to compensate for its limited scope. Therefore, TAP can affect gram-negative, gram-positive, and anaerobic bacteria, and this combination can be effective against odontogenic microorganisms.

Other: TAP

LSTR in necrotic primary second molar using nano silver particles and calcium hydroxide

EXPERIMENTAL

Nano silver particles have a strong anti-bacterial properties due to its ability to target the bacteria on different cellular levels. Calcium hydroxide has been used for so long as an intra canal medication in odontogenic infections due to its strong alkalinity that gives it its anti bacterial properties. This combination might be a future alternative to antibiotics, in an attempt to decrease the bacterial antibiotic resistance and antibiotics use.

Other: Nano silver particles and calcium hydroxide

Interventions

Combination of two materials that can possibly eradicate the mixed odontogenic infection in the periapical area and dentinal tubules in necrotic primary second molars.

LSTR in necrotic primary second molar using nano silver particles and calcium hydroxide
TAPOTHER

Triple antibiotic paste (TAP) is considered the gold standard in LSTR. It is a combination of ciprofloxacin, metronidazole and minocycline. Many anaerobic bacteria are resistant to ciprofloxacin. Hence, it is often used with metronidazole in treating mixed infections to compensate for its limited scope. Therefore, TAP can affect gram-negative, gram-positive, and anaerobic bacteria, and this combination can be effective against odontogenic microorganisms.

LSTR in necrotic primary second molar using TAP

Eligibility Criteria

Age4 Years - 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged between 4 years and 7 years.
  • Restorable necrotic mandibular second primary molars
  • Mandibular lower second primary molar with signs of radiolucency in periapical or furcation area.
  • Mandibular lower second primary molar with widening of PDL space or loss of lamina dura continuity.
  • Mandibular lower second primary molar with evidence of internal/external pathologic root resorption.
  • Signs of radiolucency in periapical or furcation area.
  • Widening of PDL space or loss of lamina dura continuity.
  • Evidence of internal/external pathologic root resorption.
  • External root resorption from 1% to 50%.

You may not qualify if:

  • Children that are not apparently healthy.
  • Lack of informed consent by the child patient's parent.
  • Patients allergic to any antibiotic used in the preparation of the TAP.
  • Unable to attend follow-up visits.
  • Refusal of participation.
  • External root resorption above 50%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (8)

  • Shetty A, Geethanjali G, Hegde A. Lesion sterilization and tissue repair in primary teeth. SRM Journal of Research in Dental Sciences. 2020;11(2):99. doi:10.4103/srmjrds.srmjrds_87_19

    BACKGROUND
  • Takushige T, Cruz EV, Asgor Moral A, Hoshino E. Endodontic treatment of primary teeth using a combination of antibacterial drugs. Int Endod J. 2004 Feb;37(2):132-8. doi: 10.1111/j.0143-2885.2004.00771.x.

    PMID: 14871180BACKGROUND
  • Motiwala MA, Habib S, Ghafoor R, Irfan S. Comparison of antimicrobial efficacy of Calcipex and Metapex in endodontic treatment of chronic apical periodontitis: a randomised controlled trial study protocol. BMJ Open. 2021 Jul 21;11(7):e048947. doi: 10.1136/bmjopen-2021-048947.

    PMID: 34290069BACKGROUND
  • Mohammadi Z, Shalavi S, Yazdizadeh M. Antimicrobial activity of calcium hydroxide in endodontics: a review. Chonnam Med J. 2012 Dec;48(3):133-40. doi: 10.4068/cmj.2012.48.3.133. Epub 2012 Dec 21.

    PMID: 23323217BACKGROUND
  • Afkhami F, Pourhashemi SJ, Sadegh M, Salehi Y, Fard MJ. Antibiofilm efficacy of silver nanoparticles as a vehicle for calcium hydroxide medicament against Enterococcus faecalis. J Dent. 2015 Dec;43(12):1573-9. doi: 10.1016/j.jdent.2015.08.012. Epub 2015 Aug 29.

    PMID: 26327612BACKGROUND
  • Zapór L. Effects of silver nanoparticles of different sizes on cytotoxicity and oxygen metabolism disorders in both reproductive and respiratory system cells. Archives of Environmental Protection. 2016;42(4):32-47. doi:10.1515/aep-2016-0038

    BACKGROUND
  • Riaz Z, Raza M, Hanif A, Haider B, Akram S, Safdar S. Antibacterial efficacy of silver nanoparticles impregnated calcium hydroxide: An in vitro study. J Pak Dent Assoc 2022;31(1):1-4

    BACKGROUND
  • Deepak BM, Prabhakar AR, Karuna YM, Sugandhan S, Zahoor N, Mahendrapa Shagale A. Evaluation of the Antibacterial Activity of Triclosan-incorporated Root Canal Filling Materials for Primary Teeth against Enterococcus faecalis. Int J Clin Pediatr Dent. 2021 May-Jun;14(3):393-397. doi: 10.5005/jp-journals-10005-1960.

    PMID: 34720513BACKGROUND

MeSH Terms

Conditions

Necrosis

Interventions

Calcium Hydroxide

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsCalcium CompoundsAnionsIonsElectrolytes

Study Officials

  • Rania A. Nasr, PhD

    Cairo University

    STUDY CHAIR

Central Study Contacts

Reem M. Wahby, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: TAP is an efficient antibacterial for the disinfection of the periapical area in the necrotic primary second molars as well as the infected dentinal tubules. It is effective against the persistent odontogenic infections.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Resident at Cairo University

Study Record Dates

First Submitted

December 13, 2022

First Posted

January 12, 2023

Study Start

February 20, 2023

Primary Completion

March 1, 2024

Study Completion

June 1, 2024

Last Updated

January 12, 2023

Record last verified: 2022-12